Tissue plasminogen activator was cost-effective compared to streptokinase in only selected patients with acute myocardial infarction
Author:
Publisher
Elsevier BV
Subject
Epidemiology
Reference15 articles.
1. The health sector's share of the gross national product;Fuchs;Science,1990
2. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction;The GUSTO investigators;N Engl J Med,1993
3. Cost-effectiveness of thrombolytic therapy with tissue plaminogen activator compared with streptokinase for acute myocardial infarction;Mark;N Engl J Med,1995
4. The impact of the cost-effectiveness study of GUSTO-1 on decision making with regard to fibrinolytic therapy;Califf;Am Heart J,1999
5. Costeffectiveness in health and medicine,1996
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Evaluating heterogeneity of treatment effects;Biostatistics & Epidemiology;2020-01-01
2. The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement: Explanation and Elaboration;Annals of Internal Medicine;2019-11-12
3. Patient Variability Seldom Assessed in Cost-effectiveness Studies;Medical Decision Making;2018-01-19
4. Understanding the Value of Individualized Information: The Impact of Poor Calibration or Discrimination in Outcome Prediction Models;Medical Decision Making;2017-04-11
5. Biases in Individualized Cost-effectiveness Analysis: Influence of Choices in Modeling Short-Term, Trial-Based, Mortality Risk Reduction and Post-Trial Life Expectancy;Medical Decision Making;2017-03-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3